ABBVIE 19/31ABBVIE 19/31ABBVIE 19/31

ABBVIE 19/31

No trades
See on Supercharts

4ABG analysis



Key facts


Issue date
Sep 26, 2019
Maturity date
Nov 18, 2031
Outstanding amount
‪650.00 M‬EUR
Face value
1,000.00EUR
Minimum denomination
100,000.00EUR
Coupon
1.25% (Fixed)
Yield to maturity
3.01%
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
Go deeper with bond data
Access the most important data for bonds including coupon rates, issue ratings, redemption data and more.